Inventor · disambiguated record
Matthew Stirling
Also filed as: STIRLING MATTHEW · STIRLING MATTHEW JOHN
7 granted patents·4 pending applications·34 citations·filing 2005–2017
83Inventor score
Files withMILLENNIUM PHARM INC7ARMITAGE Ian1BLACKBURN CHRISTOPHER1BLACKER ANDREW JOHN1MCCARRON ASHLEY SUE1
Top patents by PatentIndex Score
11 records- 0191US7935694B2Lactam compounds useful as protein kinase inhibitorsMILLENNIUM PHARM INC·Filed 2008·Granted May 3, 2011·8 cites·22 claims
- 0290US7459448B2Lactam compounds useful as protein kinase inhibitorsMILLENNIUM PHARM INC·Filed 2005·Granted Dec 2, 2008·8 cites·22 claims
- 0383US8809356B2Inhibitors of NEDD8-activating enzymeMCCARRON ASHLEY SUE·Filed 2012·Granted Aug 19, 2014·11 cites·20 claims
- 0478US10745404B2Process for the synthesis of E1 activating enzyme inhibitorsMILLENNIUM PHARM INC·Filed 2017·Granted Aug 18, 2020·1 cites·7 claims
- 0575US9850214B2Inhibitors of NEDD8-activating enzymeMILLENNIUM PHARM INC·Filed 2014·Granted Dec 26, 2017·2 cites·15 claims
- 0675US9802938B2Sulfamoylating reagentsMILLENNIUM PHARM INC·Filed 2014·Granted Oct 31, 2017·2 cites·18 claims
- 0774US8933225B2Process for the synthesis of E1 activating enzyme inhibitorsARMITAGE Ian·Filed 2008·Granted Jan 13, 2015·2 cites·14 claims
- 0859US2012178739A1Lactam compounds useful as protein kinase inhibitorsBLACKBURN CHRISTOPHER·Filed 2012·Application pending·0 cites
- 0952US2011039820A1Lactam compounds useful as protein kinase inhibitorsMILLENNIUM PHARM INC·Filed 2010·Application pending·0 cites
- 1052US2018290983A1Inhibitors of nedd8-activating enzymeMILLENNIUM PHARM INC·Filed 2017·Application pending·0 cites
- 1145US2009163719A1Catalyst compositions and their use in the de-enrichment of enantiomerically enriched substratesBLACKER ANDREW JOHN·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew Stirling files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →